Clinical Trials Browser

Phase 2 × Solid Tumor × Everolimus × Clear all

NCT04185831 2024-08-22

MEGALiT

Phase 2 Active not recruiting

Other solid neoplasm

Solid Tumor

NCT02449538 2017-02-17

Study to Evaluate the Safety and Efficacy of Everolimus, in Subjects With PIK3CA Amplification, PTEN Loss and PIK3CA Mutation Refractory Solid Tumors

Phase 2 Completed

Other solid neoplasm

Solid Tumor